Manufacturer record
Nestor Pharmaceuticals Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
34 batches manufactured by Nestor Pharmaceuticals Limited (Haryana) were declared Not of Standard Quality between January 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ACTD-05, Pantoprazole Gastro-resistant Tablets IP 40 mg (exp Dec 2027). CDTL, Hyderabad (CDSCO lab) found it not of standard quality: The sample received does not conform to i.p. 2022, i.p. addendum 2024 specification with respect to the test for Dissolution (acid stage). Listed in the September 2026 alert.
Records by type
34 records linked to Nestor Pharmaceuticals Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
34Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
34
NSQ batches since 2019
19
Products affected
Dissolution
Most common failure
Sep 2026
Latest alert
Flagged batches per year
2019 · 52021 · 12022 · 72023 · 42024 · 62025 · 42026 · 7
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro-resistant Tablets IP 40 mg | Batch ACTD-05Mfg Jan 2026 · Exp Dec 2027 | The sample received does not conform to i.p. 2022, i.p. addendum 2024 specification with respect to the test for Dissolution (acid stage) onlyDissolution | CDTL, HyderabadCDSCO lab | Sep 2026 |
| Calcium and Vitamin D3 Tablets IP (500 mg +250 IU)(Calcium 500 mg & Vitamin D3 250 IU) | Batch CUTC-39Mfg Jun 2025 · Exp May 2027 | The sample does not conform to IP standards. It fails the test Dissolution.Dissolution | RDTL, EKMState lab | Aug 2026 |
| Calcium and Vitamin D3 Tablets IP (500 mg +250 IU) | Batch CUTC-224Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to IP standards with respect to the test DissolutionDissolution | DTL, ThrissurState lab | Aug 2026 |
| Oral Rehydration Salts I.P | Batch ODSC-1010Mfg Nov 2025 · Exp Oct 2027 | Sample does not conform to IP standards. It fails the test Assay as per IP and hence declared as Not of Standard QualityAssay | RDTL ErnakulamState lab | Jul 2026 |
| Acetyl Salicylic Acid Tablets IP 75 mg | Batch PFTC-23Mfg May 2025 · Exp Apr 2027 | Dissolution and AssayAssay | SDTL, Andhra Pradesh, VijayawadaState lab | May 2026 |
| Prednisolone Tablets IP 10mg | Batch PHTC-02Mfg Jan 2025 · Exp Dec 2026 | DissolutionDissolution | DTL, ThiruvananthapuramState lab | Mar 2026 |
| Cefixime Oral Suspension 100 mg/5ml Dry Syrup 30 ml | Batch CADB-07Mfg Sep 2024 · Exp Aug 2026 | The Sample fails the test 'Description, water and Assay as per IPAssay | DTL ThiruvananthapuramState lab | Mar 2026 |
| IRON AND FOLIC ACID TABLETS IP (Iron 60mg and Folic acid 0.5mg) | Batch IQTB-39Mfg Jan 2024 · Exp Dec 2025 | Uniformity of Content & Assay for Folic AcidAssay | SDT&RL, BhubaneswarState lab | Nov 2025 |
| Ondansetron Tablets IP 4 mg | Batch ONTB-06Mfg Sep 2024 · Exp Aug 2026 | It fails the test for ?Dissolution? as per IP as Specified in the laboratory protocolDissolution | DTL ThiruvananthapuramState lab | Apr 2025 |
| Ciprofloxacin Tablets IP 250 mg | Batch CITB-02Mfg Jul 2024 · Exp Jun 2026 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Apr 2025 |
| Cefixime Oral Suspension IP Dry Syrup 30 ml | Batch CADB- 02Mfg Jun 2024 · Exp May 2026 | It fails the test Assay, water and descriptive part for oral liquids as per IP, as specified in the Laboratory ProtocolAssay | DTL ThiruvananthapuramState lab | Apr 2025 |
| Frusemide Injection IP 20 mg | Batch FRIB-03Mfg Jan 2024 · Exp Dec 2025 | It fails the test ?Sterility? as per IPSterility | DTL ThiruvananthapuramState lab | Sep 2024 |
| Cloxacillin Sodium Capsules IP 250 mg | Batch CLCA-04Mfg Apr 2023 · Exp Mar 2025 | The sample does not conform to IP Standards with respect to ?Descriptive part? of hard gelatin capsules and further tests cannot be performed due to reasons secified in the laboratory protocolOther | DTL ThiruvananthapuramState lab | Sep 2024 |
| Frusemide Injection IP 20 mg | Batch FRIB-03Mfg Jan 2024 · Exp Dec 2025 | It fails the test ?Sterility? as per IPSterility | DTL ThiruvananthapuramState lab | Aug 2024 |
| Cefixime Oral Suspension IP (Dry Syrup) | Batch CADA-02Mfg Sep 2023 · Exp Aug 2025 | It fails the test ?Assay? and ?water? as per IPAssay | DTL ThiruvananthapuramState lab | Aug 2024 |
| Cephalexin Oral Suspension IP 125/500 | Batch CHDA-01Mfg Apr 2023 · Exp Sep 2024 | It fails the test ?Assay? and Descriptive part as per IPAssay | DTL ThiruvananthapuramState lab | Jul 2024 |
| Frusemide Injection IP 20 mg | Batch FRIA-11Mfg Nov 2023 · Exp Oct 2025 | It fails the test ?Sterility? as per IPSterility | SDTL ThiruvananthapuramState lab | Apr 2024 |
| Aciclovir Tablets IP 400 mg | Batch YCTZ-01Mfg Jun 2022 · Exp May 2024 | Assay of AciclovirAssay | RDTL ChandigarhCDSCO lab | Jun 2023 |
| Iron and Folic Acid Tablets I.P. | Batch IQTZ-371Mfg Dec 2022 · Exp Nov 2024 | Description, Assay and Uniformity of Content of Folic AcidAssay | CDTL KolkataCDSCO lab | Mar 2023 |
| Trypsin- Chymotrypsin Tablets (CHYMORAL FORTE TABLETS) | Batch 2JH3H019Mfg Apr 2021 · Exp Mar 2023 | Disintegration test (Acid Medium)Disintegration | RDTL ChandigarhState lab | Jan 2023 |
| Telmisartan Tablets IP 40 mg | Batch TETY-01Mfg Apr 2021 · Exp Mar 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2023 |
| Ondansetron Tablets IP 4 mg | Batch ONTZ-07Mfg Apr 2022 · Exp Mar 2024 | AssayAssay | RDTL ChandigarhCDSCO lab | Nov 2022 |
| Telmisartan Tablets I.P. 40 mg | Batch TETY-01Mfg Apr 2021 · Exp Mar 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Telmisartan Tablets IP 40 mg | Batch TETY-01Mfg Apr 2021 · Exp Mar 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
| IRON AND FOLIC ACID TABLETS IP | Batch IQTY-312Mfg Nov 2021 · Exp Oct 2023 | Uniformity of Content (FolicUniformity of weight/content | RDTL ChandigarhCDSCO lab | Jun 2022 |
| Telmisartan Tablets IP 40mg | Batch TETY-01Mfg Apr 2021 · Exp Mar 2023 | DissolutionDissolution | RDTL GuwahatiState lab | May 2022 |
| Telmisartan Tablets IP 40mg | Batch TETY-01Mfg Apr 2021 · Exp Mar 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2022 |
| Telmisartan Tablets IP 40 mg | Batch TETY-01Mfg Apr 2021 · Exp Mar 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2022 |
| Telmisartan Tablets IP 40 mg | Batch TETY-01Mfg Apr 2021 · Exp Mar 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2021 |
| Ciprofloxacin Tablets IP 250 mg | Batch (10)CITW-31Mfg Apr 2019 · Exp Mar 2021 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Nov 2019 |
| Primaquine Tablets IP 2.5mg | Batch PJVT-01Mfg Feb 2018 · Exp Jan 2020 | Uniformity of Content, Dissolution and AssayAssay | CDL KolkataCDSCO lab | Sep 2019 |
| Ciprofloxcin Tablets I.P. 500mg | Batch RCTW-06Mfg Jan 2019 · Exp Dec 2021 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2019 |
| Calcium and Vitamin D3 Tablets IP (500 mg + 250 IU) | Batch CWTV-56Mfg Sep 2018 · Exp Aug 2020 | Assay of Vitamin D3Assay | CDTL MumbaiCDSCO lab | Jul 2019 |
| PARACETAMOL TABLETS I.P. 500 MG | Batch PTTV-38Mfg Jan 2018 · Exp Dec 2020 | Dissolution (Paracetamol)Dissolution | RDTL ChandigarhCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.